NCT00227240View on ClinicalTrials.gov

Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

CompletedOBSERVATIONAL
Enrollment

753

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Plaque Psoriasis
Trial Locations (2)

80337

Pfizer Investigational Site, München

81366

Pfizer Investigational Site, Munich

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00227240 - Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis | Biotech Hunter | Biotech Hunter